CDC Awards Contract to PharmaJet® for Development of Needle‐Free Intradermal Vaccine Delivery Device GOLDEN, Colo. – Jan. 27, 2011 – The Centers for Disease Control (CDC) has awarded PharmaJet with a substantial grant to develop needle-free injection devices for intradermal (ID) vaccine delivery. January 27, 2011NewsBy Pharmajet Administrator
